Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Schwalen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|October 13, 2022
PROTAC technology: A new drug design for chemical biology with many challenges in drug discoveryNicolas Guedeney, Marie Cornu, Florian Schwalen, et al.
Biologie Aujourd'Hui|January 27, 2025
[Exploring protein degradation pathways as therapeutic innovations]Marie Cornu, Thomas Lemaitre, Florian Schwalen, et al.
Expert Opinion on Drug Discovery|January 19, 2024
Molecular glue degraders: exciting opportunities for novel drug discoveryThomas Lemaitre, Marie Cornu, Florian Schwalen, et al.
Journal of Medicinal Chemistry|January 14, 2025
UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?Florian Schwalen, Côme Ghadi, Léonie Ibazizene, et al.
RSC Advances|July 22, 2022
Pd-catalyzed C-C and C-N cross-coupling reactions in 2-aminothieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one series for antiplasmodial pharmacomodulationRomain Mustière, Prisca Lagardère, Sébastien Hutter, et al.
Chemmedchem|October 4, 2024
Towards New Anti-Inflammatory Agents: Design, Synthesis and Evaluation of Molecules Targeting XIAP-BIR2Marc Farag, Nicolas Guedeney, Florian Schwalen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|October 13, 2022
PROTAC technology: A new drug design for chemical biology with many challenges in drug discoveryNicolas Guedeney, Marie Cornu, Florian Schwalen, et al.
Biologie Aujourd'Hui|January 27, 2025
[Exploring protein degradation pathways as therapeutic innovations]Marie Cornu, Thomas Lemaitre, Florian Schwalen, et al.
Expert Opinion on Drug Discovery|January 19, 2024
Molecular glue degraders: exciting opportunities for novel drug discoveryThomas Lemaitre, Marie Cornu, Florian Schwalen, et al.
Journal of Medicinal Chemistry|January 14, 2025
UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?Florian Schwalen, Côme Ghadi, Léonie Ibazizene, et al.
RSC Advances|July 22, 2022
Pd-catalyzed C-C and C-N cross-coupling reactions in 2-aminothieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one series for antiplasmodial pharmacomodulationRomain Mustière, Prisca Lagardère, Sébastien Hutter, et al.
Chemmedchem|October 4, 2024
Towards New Anti-Inflammatory Agents: Design, Synthesis and Evaluation of Molecules Targeting XIAP-BIR2Marc Farag, Nicolas Guedeney, Florian Schwalen, et al.
Pageof 1